Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 111601-111650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03000244
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
N/ARecruiting
2,000 participants
Started: Apr 26, 2017 · Completed: Aug 12, 2050
2 conditions1 sponsor1 location
NCT02633098
A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer
PHASE2Recruiting
200 participants
Started: Apr 26, 2017 · Completed: Oct 31, 2025
2 conditions1 sponsor8 locations
NCT03130595
West Sweden Parkinson Objective Measurement Registry Study
N/AActive, not recruiting
320 participants
Started: Apr 26, 2017 · Completed: Dec 31, 2030
3 conditions2 sponsors1 location
NCT03133650
A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing
PHASE1Active, not recruiting
12 participants
Started: Apr 26, 2017 · Completed: Feb 23, 2026
2 conditions3 sponsors3 locations
NCT03049033
NMT for Parkinson's Disease
NARecruiting
100 participants
Started: Apr 26, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04186208
Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients
N/AActive, not recruiting
42 participants
Started: Apr 25, 2017 · Completed: Jun 30, 2026
1 condition3 sponsors6 locations
NCT03141684
Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
PHASE2Active, not recruiting
63 participants
Started: Apr 25, 2017 · Completed: Oct 31, 2026
2 conditions1 sponsor42 locations
NCT03091725
Postprandial Nutrient Homeostasis Before and After Weight Loss Induced by Low-calorie Diet or RYGB
NARecruiting
30 participants
Started: Apr 25, 2017 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT03051464
No Surgery Trial / Two Dose-escalation Strategies
PHASE2/PHASE3Recruiting
131 participants
Started: Apr 25, 2017 · Completed: Jan 31, 2030
1 condition1 sponsor4 locations
NCT03096093
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
PHASE1/PHASE2Active, not recruiting
34 participants
Started: Apr 25, 2017 · Completed: Feb 28, 2026
2 conditions7 sponsors2 locations
NCT07206888
Advanced Ultrasound Signal Processing of Suspicious Breast Images
N/AEnrolling by invitation
252 participants
Started: Apr 25, 2017 · Completed: Jan 1, 2037
3 conditions1 sponsor1 location
NCT03098511
CT-Perfusion for Neurological Diagnostic Evaluation
NAActive, not recruiting
333 participants
Started: Apr 25, 2017 · Completed: Aug 31, 2024
1 condition2 sponsors14 locations
NCT02964078
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
PHASE2Active, not recruiting
27 participants
Started: Apr 25, 2017 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT03275610
Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty
N/AEnrolling by invitation
100 participants
Started: Apr 24, 2017 · Completed: Apr 23, 2026
1 condition1 sponsor1 location
NCT03241420
Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease
N/AActive, not recruiting
600 participants
Started: Apr 24, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03292263
ASCT With Nivolumab in Patients With Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Apr 24, 2017 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT03121014
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
PHASE2Active, not recruiting
38 participants
Started: Apr 24, 2017 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT04846829
Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)
EARLY_PHASE1Active, not recruiting
30 participants
Started: Apr 24, 2017 · Completed: Apr 24, 2028
1 condition1 sponsor1 location
NCT03137472
TMS for Complex Regional Pain Syndrome
NARecruiting
40 participants
Started: Apr 24, 2017 · Completed: Jun 29, 2026
1 condition5 sponsors1 location
NCT03016871
Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL
PHASE2Active, not recruiting
78 participants
Started: Apr 24, 2017 · Completed: Apr 30, 2026
2 conditions2 sponsors4 locations
NCT03116568
Bacterial Transmission In Utero and IBD Risk
N/AActive, not recruiting
180 participants
Started: Apr 24, 2017 · Completed: Sep 27, 2027
3 conditions1 sponsor1 location
NCT03073278
Focal Radiotherapy for Previously Treated Prostate Cancer Patients
NARecruiting
36 participants
Started: Apr 24, 2017 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT03346889
Vestibular Outcomes in Vestibular Schwannoma
N/AActive, not recruiting
155 participants
Started: Apr 23, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03141437
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
NAActive, not recruiting
130 participants
Started: Apr 23, 2017 · Completed: Apr 30, 2027
6 conditions2 sponsors1 location
NCT02966886
TSA Techniques in Glenohumeral OA
NARecruiting
216 participants
Started: Apr 23, 2017 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03023631
Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
PHASE4Active, not recruiting
48 participants
Started: Apr 23, 2017 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT02870738
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
PHASE2Recruiting
128 participants
Started: Apr 21, 2017 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT03140358
The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
PHASE3Active, not recruiting
300 participants
Started: Apr 21, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03125642
Auto Stem Cell Transplant for Lymphoma Patients
PHASE2Recruiting
150 participants
Started: Apr 20, 2017 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT05901077
European Cystinosis Cohort
N/ARecruiting
400 participants
Started: Apr 20, 2017 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT03083405
Selected Disorders and Sleep Bruxism
N/AEnrolling by invitation
100 participants
Started: Apr 20, 2017 · Completed: Dec 31, 2025
9 conditions1 sponsor1 location
NCT03347786
Verapamil for Neuroprotection in Stroke
PHASE1/PHASE2Recruiting
60 participants
Started: Apr 20, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT03865264
Living Organ Donor Recovery Enhancement Program
NAEnrolling by invitation
60 participants
Started: Apr 20, 2017 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03148600
Rehabilitation After Ileo-anal Pouch Surgery
NARecruiting
60 participants
Started: Apr 20, 2017 · Completed: Dec 31, 2025
3 conditions1 sponsor2 locations
NCT02898818
Vaginal and Oral Microbiome Crosstalk
N/ARecruiting
520 participants
Started: Apr 19, 2017 · Completed: Sep 30, 2027
2 conditions2 sponsors1 location
NCT03076554
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
PHASE2Active, not recruiting
56 participants
Started: Apr 19, 2017 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT03155061
Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
183 participants
Started: Apr 19, 2017 · Completed: Mar 31, 2027
1 condition1 sponsor22 locations
NCT03146676
The Ohio State University Dermatology Biorepository
N/ARecruiting
175 participants
Started: Apr 19, 2017 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06348693
Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
N/ARecruiting
400 participants
Started: Apr 19, 2017 · Completed: Nov 21, 2025
3 conditions1 sponsor1 location
NCT03275155
Pathophysiology and Risk of Atrial Fibrillation Detected After Ischemic Stroke
N/AActive, not recruiting
100 participants
Started: Apr 18, 2017 · Completed: May 7, 2026
3 conditions6 sponsors1 location
NCT03662607
Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA
NAActive, not recruiting
180 participants
Started: Apr 18, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03229863
An Examination of Infants' Microbiome, Nutrition, and Development Study.
NAActive, not recruiting
102 participants
Started: Apr 18, 2017 · Completed: Mar 10, 2027
2 conditions3 sponsors1 location
NCT03286634
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
PHASE2Recruiting
60 participants
Started: Apr 18, 2017 · Completed: Mar 31, 2033
3 conditions1 sponsor10 locations
NCT02567422
Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer
PHASE1Active, not recruiting
43 participants
Started: Apr 17, 2017 · Completed: May 14, 2026
12 conditions1 sponsor19 locations
NCT02692872
Screening for Alpha Thalassemia in Healthy Volunteers
N/AActive, not recruiting
367 participants
Started: Apr 17, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03090230
Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta
NAActive, not recruiting
50 participants
Started: Apr 17, 2017 · Completed: Nov 22, 2025
1 condition1 sponsor16 locations
NCT03122522
A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
PHASE2Active, not recruiting
70 participants
Started: Apr 17, 2017 · Completed: Apr 30, 2026
1 condition2 sponsors14 locations
NCT03109210
Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea
NAActive, not recruiting
384 participants
Started: Apr 15, 2017 · Completed: Jun 30, 2026
2 conditions2 sponsors2 locations
NCT03077776
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NAActive, not recruiting
149 participants
Started: Apr 14, 2017 · Completed: May 31, 2026
1 condition2 sponsors10 locations
NCT02942368
Adaptive tDCS for Treatment-Resistant MDD
NAActive, not recruiting
25 participants
Started: Apr 14, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor1 location